NAD+ 1g & Tirzepatide - A UK Report
The recent landscape of metabolic support in the UK is seeing increasing interest in the pairing of high-dose NAD+ supplementation – often at 1g dosage – and the novel medication Retatrutide (or its related Tirzepatide). Clinicians are investigating potential outcomes regarding weight management